The two pharma stocks offer investors the upside of a coronavirus vaccine with the peace of mind of century-old businesses.
News & Analysis: Mylan
There really isn't a downside to this deal.
The Federal Trade Commission has signed off on the deal.
FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments
The agency found no evidence to support the theory that the antimalarial drugs touted by President Trump are effective against the coronavirus.
Cheaper insulin is on its way.
Have extra cash to spare? These drug stocks are significantly undervalued and could make you wealthy in the long run.
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
Mylan will distribute the drug as a COVID-19 treatment in 127 low- and middle-income countries.
The COVID-19 pandemic helped the drugmaker's sales more than it hurt.
Regulators take different approaches to the unapproved medications.